Panama rewrote its medicines law in 2024. Law 419, Executive Decree 27, the Penal Code and Law 68, article by article, on unregistered products, personal import, advertising and consent.
Panama’s peptide law for physicians, and why US clinics should care Read More »
Since October 2025 Panama restricts who may inject filler substances. Behind the law is a regional history of biopolymers, deadly ‘vitamin drips’ and mycobacterial outbreaks.
Panama Law 491, IV drips and mycobacteria: lessons for US clinics Read More »
Tourism packages, Instagram promotion and six warnings from the bioethics committee to MINSA in ten years. In 2026, Panamanian scientists mapped the market and MINSA opened files.
Stem cells in Panama: what happened, and why US clinics should care Read More »
In 2026 three Latin American regulators warned about peptides and GLP-1s sold on social media, from BPC-157 to retatrutide. Most of the same names have no lawful US pathway either.
Peptides on Instagram: what Colombia, Guatemala and Mexico flagged Read More »
